Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Clark, San Diego
Craig Clark, San Diego, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20100288056 | Contamination Control for Liquid Handling - A structure for holding sample-containing receptacles includes a cover with holes formed therein through which the receptacles can be accessed with a substance transfer mechanism, such as a robotic pipettor. When the transfer mechanism is inserted into and then withdrawn from a receptacle, a string of viscous material may be suspended from the mechanism. A viscous string removal element adjacent each opening engages the string of viscous material and dislodges the string from the mechanism when the mechanism moves in a prescribed path with respect to the removal element. A sample rack configured to hold receptacles and to be inserted into the structure below the cover includes a sample rack having receptacle-receiving pockets, each with a resilient element and a positioning feature for holding receptacles of varying sizes in a predetermined position within the receptacle receiving pocket, and a cover including features for preventing a receptacle from being pulled out of its receptacle-receiving pocket when the transfer mechanism is withdrawn from the receptacle. | 11-18-2010 |
David Louis Clark, San Diego, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20080255063 | 3-B-D-RIBOFURANOSYLTHIAZOLO[4,5-d]PYRIMIDINE NUCLEOSIDES AND USES THEREOF - The invention is directed to 3-β-D-ribofuranosylthiazolo[4,5-d]pyrimidine nucleosides and pharmaceutical compositions containing such compounds that have immunomodulatory activity. The invention is also directed to the therapeutic or prophylactic use of such compounds and compositions, and to methods of treating diseases and disorders described herein, by administering effective amounts of such compounds. | 10-16-2008 |
| 20100261667 | 3- -D-RIBOFURANOSYLTHIAZOLO[4-5-d]PYRIMIDINE NUCLEOSIDES AND USES THEREOF - The invention is directed to 3-β-D-ribofuranosylthiazolo[4,5-d]pyrimidine nucleosides and pharmaceutical compositions containing such compounds that have immunomodulatory activity. The invention is also directed to the therapeutic or prophylactic use of such compounds and compositions, and to methods of treating diseases and disorders described herein, by administering effective amounts of such compounds. | 10-14-2010 |
Kevin M. Clark, San Diego, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20090145428 | System and Method for Controlling Supply of Oxygen Based on Breathing Rate - A portable oxygen concentrator system weighing 4-20 pounds that is adapted to be readily transported by a user and deliver oxygen to the user includes a rechargeable energy source; a concentrator powered by said energy source and adapted to convert ambient air into concentrated oxygen gas for the user; an inspiration sensor that senses respiratory activity of the user, and produces a signal in response thereto; and a control unit that receives the signal in response to sensed respiratory activity, determines a breath rate based in part on the received signal in response to sensed respiratory activity and controls the portable oxygen concentrator system to deliver oxygen flow sufficient to meet oxygen demand of the user based at least in part on the determined breath rate. | 06-11-2009 |
Michael L. Clark, San Diego, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20080308650 | Gear Driven Sprinkler with Top Turbine - A sprinkler comprises a nozzle, a turbine and a gear train reduction. The gear train reduction has an output stage that is coupled to the nozzle. The turbine is located between the nozzle and the gear train reduction and is coupled to an input stage of the gear train reduction. | 12-18-2008 |
Ross Clark, San Diego, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20080227892 | Paint formulations comprising cellulose ether/network building polymer fluid gel thickeners - Paint formulations that exhibit improved performance characteristics due to the presence of a combination of a cellulose ether (carboxymethylcellulose and/or hydroxyethylcellulose) and a network building polymer (gellan gum, carrageenan, etc., as examples) as a thickening system therein are provided. Such a combination permits long-term shelf stability of the paint formulation while simultaneously according effective flow, leveling, and other important properties to the final paint formulation. The combination of the cellulose ether and a network building polymer allows for a lower viscosity cellulosic compound to impart the desired rheological behavior therein while also permitting the other desirable characteristics noted above. Such paint compositions also exhibit improved atomization for spray applications with such a thickening system. | 09-18-2008 |
| 20090306254 | Thickening System and Method - Paint formulations that exhibit improved performance characteristics due to the presence of a combination of a cellulose ether (carboxymethylcellulose and/or hydroxyethylcellulose) and a network building polymer (gellan gum, carrageenan, etc., as examples) as a thickening system therein are provided. Such a combination permits long-term shelf stability of the paint formulation while simultaneously according effective flow, leveling, and other important properties to the final paint formulation. The combination of the cellulose ether and a network building polymer allows for a lower viscosity cellulosic compound to impart the desired rheological behavior therein while also permitting the other desirable characteristics noted above. Such paint compositions also exhibit improved atomization for spray applications with such a thickening system. | 12-10-2009 |
Ryan Clark, San Diego, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20110082164 | POLYCYCLIC COMPOUNDS AS LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS - Described herein are compounds that are antagonists of lysophosphatidic receptor(s). Also described are pharmaceutical compositions and medicaments that include the compounds described herein, as well as methods of using such antagonists, alone and in combination with other compounds, for treating LPA-dependent or LPA-mediated conditions or diseases. | 04-07-2011 |
| 20110112134 | Tricyclic Antagonists of Prostaglandin D2 Receptors - Described herein are compounds that are antagonists of PGD | 05-12-2011 |